PMC9887188_01
PMC9887188_02
Subject's relevant episodes of care. The disease-associated episodes of care are presented in the figure.
fonc-12-1101530-g001.jpg
PMC9887188_02_fonc-12-1101530-g001.jpg
f1
African, 20.9% European, and 76% Native American. A timeline of the relevant episodes of care is depicted in  Figure 1 .
BRAF genetic mutation identified in the patient by NGS. Proteins were visualized with Protter. The red circle highlights the identified Val600Glu mutation in the BRAF gene.
fonc-12-1101530-g002.jpg
PMC9887188_02_fonc-12-1101530-g002.jpg
f2
KIT genetic mutation identified in the patient by NGS. Proteins were visualized with Protter. The red circle highlights the identified Leu678Phe mutation in the KIT gene.
fonc-12-1101530-g003.jpg
PMC9887188_02_fonc-12-1101530-g003.jpg
f3
Sanger Sequencing. Similarly, in the KIT gene, a heterozygous mutation led to a thymine change to cytosine at position 2032, which resulted in an amino acid change from Leucine to Phenylalanine at position 678 ( Figure 3 ).